There's just a lack of interest in tis atm, and lots of other biotechs are looking hot.
They say that all is on track for sales to start in June, which is fantastic. However the lack of detail hasn't got investors excited yet. I'm sure investors will become excited about tis again, once we have some real good news (like european approval).
As for a cap raising, I don't think it is needed. Most of our costs are before sales start, like stocking up, approval applications etc. However if more cash is needed, remember that Quantillies offer non diluting funding options as part of the working with them (eg loans offset by future sales).
There are times when investors are all over a stock, and times when they are not interested (or watching to see how low something can go).
But once it's clear that sales will start, then I'm sure the sp will rise, and rise on substance rather than the usual hot air.
cheers
- Forums
- ASX - By Stock
- share price
There's just a lack of interest in tis atm, and lots of other...
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online